Advertisment

Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:1030

Official publication of the Indian Society of Nephrology
  Search
 
  
 ~  Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~  Article in PDF (333 KB)
 ~  Citation Manager
 ~  Access Statistics
 ~  Reader Comments
 ~  Email Alert *
 ~  Add to My List *
* Registration required (free)  

 
   References
   Article Tables

 Article Access Statistics
    Viewed2422    
    Printed82    
    Emailed0    
    PDF Downloaded146    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

 


 
  Table of Contents  
LETTER TO EDITOR
Year : 2012  |  Volume : 22  |  Issue : 5  |  Page : 401-402
 

Detection of ESBL in E.coli and K. pneumoniae isolated from urinary tract infection


1 Department of Microbiology, BLDEU's Shri B. M. Patil Medical College, Bijapur, Karnataka, India
2 Department of Microbiology, RIMS, Raichur, Karnataka, India

Date of Web Publication27-Nov-2012

Correspondence Address:
B C Metri
# 7, Old Staff Quarters, Near Lingad Gudi, BLDEU's Shri B. M. Patil Medical College Campus, Bijapur, Karnataka -586 103
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-4065.103919

Rights and Permissions



How to cite this article:
Metri B C, Jyothi P, Peerapur B V. Detection of ESBL in E.coli and K. pneumoniae isolated from urinary tract infection. Indian J Nephrol 2012;22:401-2

How to cite this URL:
Metri B C, Jyothi P, Peerapur B V. Detection of ESBL in E.coli and K. pneumoniae isolated from urinary tract infection. Indian J Nephrol [serial online] 2012 [cited 2022 Aug 16];22:401-2. Available from: https://www.indianjnephrol.org/text.asp?2012/22/5/401/103919


Sir,

Microorganisms responsible for urinary tract infection (UTI) such as  Escherichia More Details coli and Klebsiella spp. have the ability to produce extended-spectrum ß-lactamases (ESBL) in large quantities. These enzymes are plasmid borne and confer multiple drug resistance, making urinary tract infection difficult to treat. [1] ESBLs are plasmid mediated, TEM- and SHV-derived enzymes, first isolated in Western Europe in mid-1980s, most commonly in Klebsiella spp., followed by E. coli. [2] ESBLs are enzymes capable of conferring bacterial resistance to the penicillins, first, second- and third-generation cephalosporins, and aztreonam (but not the cephamycins or carbapenems) by hydrolysis of these antibiotics. [3]

This study was undertaken to find out ESBL production in urinary isolates of E. coli and Klebsiella pneumoniae and to evaluate double disc synergy (DDS) test against Clinical and Laboratory Standards Institute (CLSI) recommended the phenotypic disc confirmatory test (PCT) test for detection of ESBLs.

A total of 229 isolates [E. coli (171) and K. pneumoniae (58)] with significant growth were studies. Screening for ESBL production was done by the disc diffusion test recommended by CLSI and screen positive isolates were confirmed by DDS and PCT.

Of the 171 E. coli isolates, ESBL production was observed in 69 (40.4 %) whereas from 58 K. pneumoniae, ESBL production was found in 26 (44.9 %) isolates. Prevalence was more among K. pneumoniae. In a study conducted in 2003, [4] the prevalence was only 18.5% amongst E. coli isolates and 25.6% among K. pneumoniae isolates. Taneja et al. [5] have reported 40.2% E. coli isolates and 51.2% of K. pneumoniae to be ESBL producers. The prevalence of ESBL in this study is high and poses a threat to treatment of serious infections due to these isolates. Most ESBL producing isolates were resistant to ampicillin, co-trimoxazole, ciprofloxacin, and ceftazidime. Under such circumstances the only treatment options are carbapenems and tigecycline that are expensive and often not available in developing countries. However, quinolones may be regarded as the treatment of choice for UTI [Table 1] due to ESBL producing organisms if there is not in vitro resistance to these drugs. [3] Unfortunately, increasing resistance of quinolones will limit the role of these in future.
Table 1: Recommended treatment for infections with ESBL-producing organism

Click here to view


This study evaluated DDS against CLSI recommended PCT for detection of ESBL. Of the two tests used in the study PCT was more sensitive. Eight six (90.5 %) of the 95 ESBL producing strains were detected by DDST. We found that PCT was an inexpensive alternative to DDS for detection of ESBL. DDS lacks sensitivity because of problem of the optimal disc space and correct storage of the clavulanate containing discs. This method is technically simple and inexpensive. [6] All the isolates positive by confirmatory methods should be reported as resistant to all cephalosporins even if the organism is susceptible by routine disc diffusion methods for antibiotic sensitivity.

 
  References Top

1.Babypadmini S, Appalaraju B. Extended spectrum ß-lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae - prevalence and susceptibility pattern in a tertiary care hospital. Indian J Med Microbiol 2004;22:172-4.  Back to cited text no. 1
[PUBMED]  Medknow Journal  
2.Chaudhary U, Aggarwal R. Extended spectrum β-lactamases (ESBL) - An emerging threat to clinical therapeutics. Indian J Med Microbiol 2004;22:75-80.  Back to cited text no. 2
[PUBMED]  Medknow Journal  
3.Paterson DL, Bonomo RA. Extended- spectrum ß-lactamases: a clinical update. Clin Microbiol Rev 2005;18:657-86.  Back to cited text no. 3
    
4.Tankhiwale SS, Jalgaonkar SV, Ahamad S, Hassani U. Evaluation of extended spectrum beta lactamase in urinary isolates. Indian J Med Res 2004;120:553-6.  Back to cited text no. 4
    
5.Taneja N, Rao P, Arora J, Dogra A. Occurrence of ESBL and Amp-C ß-lactamases and susceptibility to newer antimicrobial agents in complicated UTI. Indian J Med Res 2008;127:85-8.  Back to cited text no. 5
[PUBMED]  Medknow Journal  
6.Shukla I, Tiwari R, Agrawal M. Prevalence of extended spectrum- β-lactamase producing Klebsiella pneumoniae in a tertiary care hospital. Indian J Med Microbiol 2004;22:87-91.  Back to cited text no. 6
[PUBMED]  Medknow Journal  



 
 
    Tables

  [Table 1]

This article has been cited by
1 Antibiotic susceptibility profile of extended spectrum -lactamase producing Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca from Urinary tract infections
M. Sharmal Kumar, Arunagirinathan N., Ravikumar M.
Research Journal of Pharmacy and Technology. 2021; : 4425
[Pubmed] | [DOI]



 

Top
Print this article  Email this article
 

    

Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07